Redefined clinical spectra of diabetic foot syndrome

The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospita...

Full description

Saved in:
Bibliographic Details
Published inVascular health and risk management Vol. 14; pp. 291 - 298
Main Authors Shatnawi, Nawaf J, Al-Zoubi, Nabil A, Hawamdeh, Hasan, Khader, Yousef S, Omari, Abd El-Karim, Khammash, Muhammad R
Format Journal Article
LanguageEnglish
Published New Zealand Dove Medical Press Limited 01.01.2018
Dove Medical Press
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results.
AbstractList Purpose: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. Patients and methods: This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. Results: In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. Conclusion: Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. Keywords: diabetes mellitus, classification, diabetic foot syndrome, amputations
Nawaf J Shatnawi,1 Nabil A Al-Zoubi,1 Hasan Hawamdeh,2 Yousef S Khader,3 Abd El-Karim Omari,1 Muhammad R Khammash1 1Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan; 2Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan; 3Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan Purpose: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. Patients and methods: This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. Results: In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. Conclusion: Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results. Keywords: diabetes mellitus, classification, diabetic foot syndrome, amputations
The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. This is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. In this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. Redefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results.
PURPOSEThe aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to predict amputations. PATIENTS AND METHODSThis is a retrospective study of type 2 diabetic patients referred with DFS for management at King Abdullah University Hospital (KAUH) between January 2014 and December 2015. Data collection form and diabetic foot (DF) characteristic chart were used to document the following: demographic data, diabetes-related parameters, DF characteristics, surgical interventions and amputations. The predominant clinical presentations of DF problems (ulcer, sepsis or gangrene) were integrated with the clinical criteria for diabetic foot infection (DFI) diagnosis and classification of Infectious Diseases Association of America (IDSA)/International Working Group on Diabetic Foot (IWGDF) to redefine the clinical spectra of DFS. Related risk characteristics and amputation rate at all levels were compared between the three RCS. RESULTSIn this study, there were 95 (47.0%) septic DFS (SDFS) patients, 65 (32.2%) ulcerative DFS (UDFS) patients and 42 (20.8%) gangrenous DFS (GDFS) patients. Poor glycemic control (HbA1c >7.5%), hypertension, history of the same foot problems, duration of symptoms, revascularizations and ischemic severity were significantly different between the three RCS. UDFS had the highest rate of limb salvage without amputations (70.8%). GDFS had the highest rate for final toe amputations (52.4%) and major amputations (23.8%). Final minor amputation rate was around 20% for both SDFS and GDFS. CONCLUSIONRedefining DFS into ulcerative, septic and gangrenous by integration of the predominant clinical presentation and the clinical criteria for DFI diagnosis and classification of IDSA/IWGDF showed significant differences in amputation rate. Therefore, it can be used clinically to categorize patients with DFS to predict amputations and to help in planning their management. Further prospective studies are suggested to validate these results.
Audience Academic
Author Shatnawi, Nawaf J
Khader, Yousef S
Khammash, Muhammad R
Hawamdeh, Hasan
Omari, Abd El-Karim
Al-Zoubi, Nabil A
AuthorAffiliation 3 Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan
1 Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com
2 Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan
AuthorAffiliation_xml – name: 3 Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan
– name: 1 Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com
– name: 2 Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan
Author_xml – sequence: 1
  givenname: Nawaf J
  surname: Shatnawi
  fullname: Shatnawi, Nawaf J
  email: nshatnawi@yahoo.com
  organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com
– sequence: 2
  givenname: Nabil A
  surname: Al-Zoubi
  fullname: Al-Zoubi, Nabil A
  email: nshatnawi@yahoo.com
  organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com
– sequence: 3
  givenname: Hasan
  surname: Hawamdeh
  fullname: Hawamdeh, Hasan
  organization: Department of Basic Medical Science, Faculty of Medicine, Hashemite University, Zarqa, Jordan
– sequence: 4
  givenname: Yousef S
  surname: Khader
  fullname: Khader, Yousef S
  organization: Department of Community Medicine, Public Health and Family Medicine, Jordan University of Science and Technology, Irbid, Jordan
– sequence: 5
  givenname: Abd El-Karim
  surname: Omari
  fullname: Omari, Abd El-Karim
  email: nshatnawi@yahoo.com
  organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com
– sequence: 6
  givenname: Muhammad R
  surname: Khammash
  fullname: Khammash, Muhammad R
  email: nshatnawi@yahoo.com
  organization: Department of Surgery, Jordan University of Science and Technology, Irbid, Jordan, nshatnawi@yahoo.com
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30425505$$D View this record in MEDLINE/PubMed
BookMark eNptktuLEzEUxoOsuBd981kGBPHB1lxnJi_Csqi7sCKsl9dwkpy0WaZJnUyF_e9NbV1akDwknPzOx3eS75ycpJyQkJeMzjmT3fuf13df5t9YqxXlT8gZY10_41T2JwfnU3Jeyj2lqu0pe0ZOBZVcKarOiLxDjyEm9I0bYooOhqas0U0jNDk0PoLFKbom5Dw15SH5Ma_wOXkaYCj4Yr9fkB-fPn6_up7dfv18c3V5O3NK9tMsAEgvvHTY606zFgMH4KxVOgjbeYqcOQm2U4Gi9sJaH7rWWac47VA4Ly7IzU7XZ7g36zGuYHwwGaL5W8jjwsBY3Q1oOoUgqRfIJcjearAesMfqnlYDwlatDzut9cau0DtMdcThSPT4JsWlWeTfpuWUad1Wgbd7gTH_2mCZzCoWh8MACfOmGM6EkIJpxSv6eocuoFqLKeSq6La4uVQ9V7RXSldq_h-qLo-r6Oonh1jrRw1vDhqWCMO0LHnYTDGncgy-24FuzKWMGB7HZNRsQ2O2oTH70FT81eHTPML_UiL-AJCDvlU
CitedBy_id crossref_primary_10_1186_s13047_020_00405_z
crossref_primary_10_1097_WON_0000000000000664
crossref_primary_10_7861_clinmed_2019_0392
crossref_primary_10_1021_acsomega_3c06354
crossref_primary_10_1111_ijcp_14892
crossref_primary_10_1111_nep_13596
crossref_primary_10_1177_15347346221109057
ContentType Journal Article
Copyright COPYRIGHT 2018 Dove Medical Press Limited
2018 Shatnawi et al. This work is published and licensed by Dove Medical Press Limited 2018
Copyright_xml – notice: COPYRIGHT 2018 Dove Medical Press Limited
– notice: 2018 Shatnawi et al. This work is published and licensed by Dove Medical Press Limited 2018
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOA
DOI 10.2147/VHRM.S169502
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
Directory of Open Access Journals
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList

MEDLINE
MEDLINE - Academic

Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1178-2048
EndPage 298
ExternalDocumentID oai_doaj_org_article_75ea40d3e24a48b9abdae8eabe0d4c3b
A582508559
10_2147_VHRM_S169502
30425505
Genre Journal Article
Comparative Study
GroupedDBID ---
04C
0YH
123
29Q
2WC
53G
5VS
6PF
7RV
7X7
8AO
8FI
8FJ
8G5
AAWTL
ABUWG
ACGFO
ADBBV
ADRAZ
AFKRA
AIAGR
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AQUVI
AZQEC
BAWUL
BCNDV
BENPR
BKEYQ
BMSDO
BPHCQ
BVXVI
CCPQU
CGR
CS3
CUY
CVF
DIK
DU5
DWQXO
E3Z
EBD
EBS
ECM
EIF
EIHBH
EJD
F5P
FYUFA
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HMCUK
HYE
IAO
IHR
IHW
INH
INR
IPNFZ
ITC
KQ8
M0T
M2O
M48
M~E
NAPCQ
NPM
O5R
O5S
OK1
P2P
PGMZT
PIMPY
PQQKQ
PROAC
RIG
RNS
RPM
TR2
UKHRP
VDV
AAYXX
CITATION
TDBHL
7X8
5PM
ID FETCH-LOGICAL-c548t-faa4d3d4ce897916ef2aa21659f3b7d0e21c4ab75f0e9d3bbdf76cbc5207e3cd3
IEDL.DBID RPM
ISSN 1178-2048
1176-6344
IngestDate Tue Oct 22 15:16:38 EDT 2024
Tue Sep 17 21:26:17 EDT 2024
Fri Oct 25 05:16:25 EDT 2024
Thu Feb 22 23:55:19 EST 2024
Sat Dec 16 00:29:51 EST 2023
Tue Aug 20 21:57:20 EDT 2024
Thu Sep 26 16:56:47 EDT 2024
Sat Sep 28 08:22:29 EDT 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Keywords diabetic foot syndrome
amputations
diabetes mellitus
classification
Language English
License The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c548t-faa4d3d4ce897916ef2aa21659f3b7d0e21c4ab75f0e9d3bbdf76cbc5207e3cd3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ORCID 0000-0002-2328-9383
0000-0002-7830-6857
OpenAccessLink https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6201996/
PMID 30425505
PQID 2133431952
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_75ea40d3e24a48b9abdae8eabe0d4c3b
pubmedcentral_primary_oai_pubmedcentral_nih_gov_6201996
proquest_miscellaneous_2133431952
gale_infotracmisc_A582508559
gale_infotracacademiconefile_A582508559
gale_healthsolutions_A582508559
crossref_primary_10_2147_VHRM_S169502
pubmed_primary_30425505
PublicationCentury 2000
PublicationDate 2018-01-01
PublicationDateYYYYMMDD 2018-01-01
PublicationDate_xml – month: 01
  year: 2018
  text: 2018-01-01
  day: 01
PublicationDecade 2010
PublicationPlace New Zealand
PublicationPlace_xml – name: New Zealand
PublicationTitle Vascular health and risk management
PublicationTitleAlternate Vasc Health Risk Manag
PublicationYear 2018
Publisher Dove Medical Press Limited
Dove Medical Press
Publisher_xml – name: Dove Medical Press Limited
– name: Dove Medical Press
SSID ssj0056801
Score 2.2606704
Snippet The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to...
Purpose: The aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used...
PURPOSEThe aim of this study was to present the redefined clinical spectra of diabetic foot syndrome (RCS-DFS) and determine whether the RCS-DFS can be used to...
Nawaf J Shatnawi,1 Nabil A Al-Zoubi,1 Hasan Hawamdeh,2 Yousef S Khader,3 Abd El-Karim Omari,1 Muhammad R Khammash1 1Department of Surgery, Jordan University of...
SourceID doaj
pubmedcentral
proquest
gale
crossref
pubmed
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
StartPage 291
SubjectTerms Amputation
Amputations
Classification
Communicable diseases
Data collection
Decision Support Techniques
Diabetes Mellitus
Diabetes Mellitus, Type 2 - diagnosis
Diabetes Mellitus, Type 2 - epidemiology
Diabetes Mellitus, Type 2 - therapy
Diabetic foot
Diabetic Foot - diagnosis
Diabetic Foot - epidemiology
Diabetic Foot - therapy
Diabetic Foot Syndrome
Diabetics
Female
Foot diseases
Gangrene
Glycosylated hemoglobin
Health aspects
Humans
Hypertension
Infection
Jordan - epidemiology
Limb Salvage
Male
Medical research
Middle Aged
Original Research
Predictive Value of Tests
Prevalence
Prognosis
Retrospective Studies
Risk Assessment
Risk Factors
Sepsis - diagnosis
Sepsis - epidemiology
Sepsis - therapy
Therapeutics
Wound Infection - diagnosis
Wound Infection - epidemiology
Wound Infection - therapy
SummonAdditionalLinks – databaseName: Directory of Open Access Journals
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LT9wwELYQh4pLVQptl0IJUitOKUlsx_ERKtAKiR54iZvlx1hwSdCy_P_OxMlqIw5ceoviUeT5xuN5ZDxm7Ke3XJa8jjnVLuZo8VxuOQjUKx-FtpE6flO1xd96ficuH-TD2lVfVBOW2gMn4E6UBCuKwKESVjROWxcsNGAdFEF47vrdt9BjMJX2YFk3_cXHZaloHYgmlbzTnTwn9_Prq983Za3lkEoZjVHfs__tzrxmmqZlk2t26OIT-zg4kNlpmvg224D2M_twNfwi32HiGgJEfAzZeOox649TLmzWxSzlWp98FrtumY39CnbZ3cX57Z95PlyNkHsMMZZ5tFYEjgBAoxV6eBAra6uyljpyp0IBVemFdUrGAnTgzoWoau-8rAoF3Af-hW22XQvfWKZKrwsZg6wFxiJRN4oLaQG0iKrUTs_YrxEj85w6YBiMHAhLQ1iaAcsZOyMAVzTUt7p_gdI0gzTNe9KcsUOC36RDoCvtM6cSI1kqqcPpHPcUpH-InLfDMQJkhjpZTSj3J5SoN34yfDSK2NAQFZu10L2-IGuco1-lJfL0NYl8xRVlfyiomzE1WQwTtqcj7dNj37a7Rl8Lo8u9_4HTd7aFX2tSLmifbS4Xr3CA3tHS_egV4R_BtQ3a
  priority: 102
  providerName: Directory of Open Access Journals
Title Redefined clinical spectra of diabetic foot syndrome
URI https://www.ncbi.nlm.nih.gov/pubmed/30425505
https://search.proquest.com/docview/2133431952
https://pubmed.ncbi.nlm.nih.gov/PMC6201996
https://doaj.org/article/75ea40d3e24a48b9abdae8eabe0d4c3b
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9swED_aDsZexr6Xrcs82NiTE9v6sh7b0hIGKSVbR96EPrvAapcs_f93ku1Qs7e9CesMvtOd7k7-3Qngs9WElYSHPGIXc_R4JtfEU7QrG6jUIXb8jmiLS764pt_WbH0AbKiFSaB9azaz5vftrNn8StjKu1s7H3Bi86vlGUevhXH6_BAOUUGHFL3bfhmv053HZSl4zgmlHdo9Xscz_7lYLWffSy5ZEW-xiZl8DNBHLil17v93f37goMbgyQfe6OIZPO3DyOyk-9zncOCbF_B42f8ofwl05Z0POHTZUPuYpaLKrc7akHUnrhubhbbdZUPXgldwfXH-42yR9xck5BYTjV0etKaOOGp9LQXGeT5UWlclZzIQI1zhq9JSbQQLhZeOGOOC4NZYVhXCE-vIazhq2sa_hUyUVhYsOMYpZiRB1oJQpr2XNIhSGjmBL4OM1F3XB0Nh_hDFqqJYVS_WCZxGAe5pYvfq9KDd3qh-DZVgXtPCEV9RTWsjtXHa1x45L5AZYibwMYpfdaWgextUJwzz2Qisw8_5miiiFaLkrO6LCZCZ2M9qRHk8okTrsaPpT8MSqzgVIWeNb-__IGuEYHQlGfL0plvyPVeD5kxAjJRhxPZ4BnU5Ne_udffdf7_5Hp7goO6OgY7haLe99x8wMNqZKZrDWkzh0en55dVqmo4Xpsk4_gIMaQ-E
link.rule.ids 230,315,730,783,787,867,888,2109,27938,27939,31734,33759,53806,53808
linkProvider National Library of Medicine
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB6VIgEX3oWFQoME4pRssn7Fx1JRLdCtUGmr3iw_YQVNqiV74dczzmPVwAluUexI-TwzmRnnmzHAa6sJKwgPaeQupujxTKqJp2hXNlCpQ-z4HdkWx3x-Rj9esIstYEMtTEvat2aZVT8us2r5reVWXl3a6cATm35eHHD0WhinT2_ATbTXnA9JevcBZrxsTz0uCsFTTijt-O7xQJ7p-fxkkX0puGR5PMcm5vIxRB85pbZ3_99f6GsuakyfvOaPDu_B-YCko6F8z9aNyeyvP5o8_jPU-3C3j1CT_W74AWz56iHcWvT_4B8BPfHOB7x0yVBWmbT1miud1CHpNnOXNgl13SRDQ4THcHb4_vRgnvZnL6QWc5gmDVpTRxy1vpQCQ0gfZlrPCs5kIEa43M8KS7URLOReOmKMC4JbY9ksF55YR3Zgu6or_xQSUViZs-AYp5jsBFkKQpn2XtIgCmnkBN4Mi6-uuhYbClOTKC8V5aV6eU3gXZTMZk5sjN3eqFdfVb9mSjCvae6In1FNSyO1cdqXHpHnCIaYCexFuaquynRj3mqfYaocOXv4Om_bGdHAceWs7usUEExslTWauTuaiYZpR8OvBt1RcSiy2Spfr38iNEIwcJMMMT3pdGmDalDJCYiRlo1gj0dQd9q-4L2uPPvvJ_fg9vx0caSOPhx_eg538GbZ7TbtwnazWvsXGH815mVrbb8BHz8uBw
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF5BkSou5U0DLTUSiJOf-_Ie20IUHqmqQlHFZbVPiKB2FJwLv55ZP6IYbr1Z3rHkzzPjmbG_nUHolVGY5pj5OHAXY4h4OlbYEfAr44lQPnT8DmyLMza7JB-u6NXWqK-WtG_0Iql-XSfV4kfLrVxem3TgiaXn81MGUQvy9HRpfXob3QGfzcqhUO9ewpSV7eTjPOcsZpiQjvMehvKkX2cX8-RzzgTNwiybUM-HNH0UmNr-_f-_pbfC1JhCuRWTpvfQtwFNR0X5mawbnZg__zR6vBHc-2ivz1Sj407kAbrlqodod97_i3-EyIWzzsOhjYbtlVG7b3OlotpH3UfdhYl8XTfR0BjhMbqcvvtyOov7GQyxgVqmib1SxGJLjCsFh1TS-UKpImdUeKy5zVyRG6I0pz5zwmKtrefMaEOLjDtsLH6Cdqq6cvso4rkRGfWWMgJFjxclx4Qq5wTxPBdaTNDrQQFy2bXakFCiBJ3JoDPZ62yCToJ2NjKhQXZ7ol59l_1zk5w6RTKLXUEUKbVQ2ipXOkCeARisJ-go6FZ2u003bi6PKZTMgbsHt_OmlQiODk_OqH6_AoAJLbNGkgcjSXBQM1p-OdiPDEuB1Va5ev0boGEMCZyggOlpZ08bVINZThAfWdoI9ngF7KftD97by7MbX3mEds_fTuWn92cfn6O7cK7sPjodoJ1mtXaHkIY1-kXrcH8Bjnwwhw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Redefined+clinical+spectra+of+diabetic+foot+syndrome&rft.jtitle=Vascular+health+and+risk+management&rft.au=Shatnawi%2C+Nawaf+J&rft.au=Al-Zoubi%2C+Nabil+A&rft.au=Hawamdeh%2C+Hasan&rft.au=Khader%2C+Yousef+S&rft.date=2018-01-01&rft.pub=Dove+Medical+Press+Limited&rft.issn=1178-2048&rft.eissn=1178-2048&rft.volume=14&rft.spage=291&rft_id=info:doi/10.2147%2FVHRM.S169502&rft.externalDocID=A582508559
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1178-2048&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1178-2048&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1178-2048&client=summon